Peer Review History

Original SubmissionOctober 31, 2025
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Decision Letter - Ali R. Ansari, Editor

Dear Dr. wu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 12 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Ali R. Ansari, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following financial disclosure:

“The author(s) received no specific funding for this work.”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Please amend either the abstract on the online submission form (via Edit Submission) or the abstract in the manuscript so that they are identical.

5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: No

**********

Reviewer #1: This study extends a test of selection pressure to 49 segments of the SARS-CoV-2 genome and introduces a unified "Near-Neutral Selectionist Theory" to better explain the virus's evolution

The work is highly original, proposing a new theoretical framework. The manuscript is well-organized.

Minor Improvements:

The abstract notes that 24 segments supported the strict molecular clock (NNBST), while 25 segments did not (NNUST). The Discussion or Results should clearly explain why the UTR/TRS segments appear to have an unbalanced selection mechanism, contrasting the mechanisms driving the balance observed in the translated regions.

Add a simplified, conceptual explanation of what c/mu represents before diving into the population genetics equations.

Ensure consistent formatting of "SARS-CoV-2" (the manuscript sometimes uses "SARS-COV-2").

Reviewer #2: The overall paper is drafted in a form of review report. There are some basic ingredients of a Research Paper is missing. I have some points which can improve the quality of paper:

I. Abstract should be enhanced and can be written in a better way. Add some motivation: what is new?

II. There should be a detailed Conclusion to explain and motivate the readers.

III. The analysis focuses solely on SARS-CoV-2, a rapidly evolving RNA virus; conclusions about NNST may not generalize to organisms with different genomic architectures, population sizes, or evolutionary rates. Please see this carefully.

IV. Lacks methodological details on how c/μ ratios are calculated, validated, or corrected for potential biases like sequencing errors, recombination, or population structure that could artifact the L-shaped DFEs.

V. The criteria distinguishing "L-shaped" DFEs from other shapes and the thresholds separating NNBST from NNUST appear subjective without quantitative cutoffs or statistical validation provided.

VI. SARS-CoV-2 evolution involves immune selection, transmission bottlenecks, and recombination that may independently violate molecular clock assumptions, yet these confounding factors aren't addressed.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Revision 1

We thank the Editor and Reviewers for their careful reading of our manuscript, “Near Neutral Selectionist Theories (NNST) for SARS-CoV-2 suggested by the substitution–mutation ratio (c/µ) analysis” and for their thoughtful comments.

We have carefully revised the main manuscript and Supporting Information.

Below we provide a point-by-point response to each of the reviewer’s questions.

Reviewer #1

This study extends a test of selection pressure to 49 segments of the SARS-CoV-2 genome and introduces a unified "Near-Neutral Selectionist Theory" to better explain the virus's evolution

The work is highly original, proposing a new theoretical framework. The manuscript is well-organized.

We thank the reviewer for these comments.

Comment 1.

“The abstract notes that 24 segments supported the strict molecular clock (NNBST), while 25 segments did not (NNUST). The Discussion or Results should clearly explain why the UTR/TRS segments appear to have an unbalanced selection mechanism, contrasting the mechanisms driving the balance observed in the translated regions.”

We have added an explanation of the deviating molecular clock presence in the TR vs the UTR/TRS genomic segments, being reflective of their different functional roles, in the Discussion. TRs encode protein that performs various different functions, and nonsynonymous nucleotide substitutions (change protein sequence, lower sequence divergence) are generally less tolerated and are fixed at a slower rate than synonymous nucleotide substitutions (do not change protein sequence, higher sequence divergence) in TRs. The slow nonsynonymous nucleotide substitution rates could be balanced by the faster synonymous nucleotide substitution rates, which may produce the strict molecular clock feature in the total substitution rate. In contrast, UTRs/TRSs have regulatory functions that mainly control protein expression and protein-RNA interactions. Sequence constraint in these genomic segments is rather high, which is not balanced by other mutation types explored in this study. Therefore, an absence of the strict molecular clock feature is often observed in these UTRs/TRSs.

Comment 2.

“Add a simplified, conceptual explanation of what c/µ represents before diving into the population genetics equations.”

We have added a short, plain-language explanation of c/µ in the Introduction, before the technical discussion of the c/µ framework. This paragraph explains that c/µ compares how often mutations arise (µ) to how often they fix (c), and that c/µ > 1, = 1, and < 1 correspond to beneficial, neutral, and deleterious selection, respectively.

Comment 3.

“Ensure consistent formatting of ‘SARS-CoV-2’ (the manuscript sometimes uses ‘SARS-COV-2’).”

We have replaced all occurrences of “SARS-COV-2” and similar variants with the consistent form “SARS-CoV-2” throughout the manuscript.

Reviewer #2:

The overall paper is drafted in a form of review report. There are some basic ingredients of a Research Paper is missing. I have some points which can improve the quality of paper:

I. Abstract should be enhanced and can be written in a better way. Add some motivation: what is new?

We have rewritten the Abstract to better highlight the novelty and motivation of our work. We introduce c/µ in intuitive terms to motivate the elucidation of species fitness using empirical sequence data. We also emphasize the lack of a theoretical framework to explain the non-strict molecular clock behavior of UTR/TRS genomic segments, as per our prior report.

II. There should be a detailed Conclusion to explain and motivate the readers.

We already provide a Conclusion section following the Discussion. We also added a concluding sentence urging the re-examination of intra-species molecular evolution using available empirical sequence data to highlight that a blend of genetic drifting, natural selection and nearly neutral selection contribute to species molecular evolution.

III. The analysis focuses solely on SARS-CoV-2, a rapidly evolving RNA virus; conclusions about NNST may not generalize to organisms with different genomic architectures, population sizes, or evolutionary rates. Please see this carefully.

In response to the reviewer’s concern that NNST may be applicable only to SARS-CoV-2, we emphasize that our framework is explicitly grounded in, and supported by, genome-scale comparative evidence far beyond viral evolution. phyloP is a well-established comparative-genomics method that quantifies deviations from neutral evolution across dozens to hundreds of species, from primates to all vertebrates. Critically, the phyloP score −ln(r) is mathematically equivalent (up to sign convention) to ln(c/μ), allowing existing phyloP genome-wide distributions to be reinterpreted directly within a mutation–selection framework. Analysis of the classic 46-species phyloP histograms—covering 2.85 billion nucleotide positions—reveals a robust, recurring pattern across evolutionary scales: a dominant near-neutral mode, persistent right-skew toward conservation, and a non-vanishing accelerated tail. This structure is inconsistent with strict Kimura Neutral Theory (which predicts centering at zero after sufficient divergence) and with strong selectionist models (which would suppress the near-neutral peak), but is exactly the qualitative signature predicted by NNST. Moreover, the scale dependence of the distributions—L-shaped at shallow divergence (mirroring rapidly evolving systems like SARS-CoV-2), broadening yet remaining biased at deep phylogenetic scales—demonstrates that near-neutral balance is not a virus-specific phenomenon, but a general property of genome evolution. Thus, rather than being limited to SARS-CoV-2, NNST provides a unifying theoretical interpretation for empirical patterns already observed across vertebrate and mammalian genomes, as independently captured by decades of phyloP analyses.

IV. Lacks methodological details on how c/μ ratios are calculated, validated, or corrected for potential biases like sequencing errors, recombination, or population structure that could artifact the L-shaped DFEs.

We have added a “Calculation of c, µ, and c/µ” subsection specifying how c is obtained from time-resolved substitution timelines and how µ is approximated using the effective neutral substitution rate, in the Methods. We added a “Validation and bias control” subsection describing how we use Nextstrain’s curated datasets and additional site/segment filters to limit sequencing artifacts, exclude instances of recombination and compare time-based and position-based c/µ estimates as an internal consistency check. We explicitly link these steps to the L-shaped DFEs and emphasize that the observed L-shapes persist after these controls, indicating the L-shaped DFEs are not likely artificially produced.

V. The criteria distinguishing "L-shaped" DFEs from other shapes and the thresholds separating NNBST from NNUST appear subjective without quantitative cutoffs or statistical validation provided.

We have clarified and quantified how DFE shapes and theoretical regimes are defined in the Methods. Specifically, we have included a plain-language description on defining the L-shaped c/u DFE and in defining the three boundary points in quantifying the different mutation types in Step 5 and 6 of the Methods section. A more technical description of defining these information, as well as the comparison of our approach to that defined by Ohta, is continued in the following paragraph.

VI. SARS-CoV-2 evolution involves immune selection, transmission bottlenecks, and recombination that may independently violate molecular clock assumptions, yet these confounding factors aren't addressed.

We have included a paragraph in the Discussion of how the differing biological processes (immune selection, transmission bottlenecks, and recombination) could violate the molecular clock feature and how these processes are either absent or present in the current SARS-CoV-2 genomic dataset analyzed in this study. In brief, we outline that the impact of immune selection on key SARS-CoV-2 genomic segments (i.e. ORF6 and ORF7a proteins) and their absent molecular clock feature could be explained by host immune-driven selection. The impact of transmission bottle necks on the molecular clock was just outlined. Conversely, the impact of recombination on our SARS-CoV-2 genomic dataset is likely minimal since it does not contain viral sequences from the Omicron XBB or Deltacron lineages.

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Attachments
Attachment
Submitted filename: reviewer_comments_final.pdf
Decision Letter - Ali R. Ansari, Editor

<p>Near Neutral Selectionist Theories (NNST) for SARS-COV-2 suggested by the substitution-mutation ratio (c/µ) analysis

PONE-D-25-58778R1

Dear Dr. wu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ali R. Ansari, Ph.D.

Academic Editor

PLOS One

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Ali R. Ansari, Editor

PONE-D-25-58778R1

PLOS One

Dear Dr. Wu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Ali R. Ansari

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .